Biohaven Ltd. (BHVN) Form 8-K — Jul 9, 2026
Biohaven Ltd. announced a leadership transition effective July 13, 2026, with Chief Scientific Officer Bruce Car, Ph.D., retiring from his full-time role to become the part-time Chief Innovation Officer. Dr. Car will focus on scientific initiatives and external collaborations, specifically with Bexorg, Inc., and will receive a fifty percent salary reduction to reflect his new schedule.
Key figures
- Salary Reduction
- 50%
Price after filing
1 day: -7.4%7 days: -15.6%30 days: -12.7%
Close on the filing date to close N calendar days later (from $16.79). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.